PPA
TLIS

Parametric Portfolio Associates’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Parametric Portfolio Associates’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$196K Buy
9,261
+4,198
+83% +$145K ﹤0.01% 3448
2021
Q4 		$305K Sell
5,063
-135
-3% -$10.1K ﹤0.01% 3284
2021
Q3 		$487K Buy
5,198
+1,832
+54% +$244K ﹤0.01% 3123
2021
Q2 		$557K Buy
3,366
+591
+21% +$100K ﹤0.01% 3037
2021
Q1 		$535K Buy
+2,775
New +$692K ﹤0.01% 3475

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's TLIS Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Talis Biomedical Corporation Common Stock (TLIS) stake by 83% in Q1 2022, buying an estimated $145K and bringing the position to 9,261 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #3448.

Parametric Portfolio Associates first reported a position in TLIS in Q1 2021 and has held it in 5 quarters since. The position peaked at $557K in Q2 2021. 44 funds tracked by Wall St. Rank hold TLIS as of Q1 2022.

  • Parametric Portfolio Associates held 9,261 shares of Talis Biomedical Corporation Common Stock worth $196K as of Q1 2022.
  • Parametric Portfolio Associates bought 4,198 Talis Biomedical Corporation Common Stock shares in Q1 2022, an estimated $145K.
  • Talis Biomedical Corporation Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3448 holding.
  • Parametric Portfolio Associates first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Talis Biomedical Corporation Common Stock position peaked at $557K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.